Type 2 diabetic neuropathy. Diabetes mellitus due to underlying condition with diabetic nephropathy
Conditions
Interventions
Intervention 1: Intervention group: People with type 2 diabetic neuropathy will take 2 D3fort supplements and 1 thiamine 300 mg daily for 12 weeks. Intervention 2: Control group: Subjects will receiv
Sponsors
Iran University of Medical Sciences
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diagnosing neuropathy in people with type 2 diabetes by a doctor based on clinical symptoms (motion strength, pain intensity and paresthesia) Age range from 20 to 65 years Completion of written consent Not suffering from certain diseases such as cancer, severe kidney disease (ESRD), liver cirrhosis and autoimmune diseases.
Exclusion criteria
Exclusion criteria: Following a special diet such as ketogenic, fasting, etc. Pregnancy and breastfeeding History of persistent diarrhea or vomiting and severe gastric reflux Severe vitamin D deficiency and very high vitamin D levels
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of neuropathy symptoms. Timepoint: Before the start of the intervention and 12 weeks after the intervention. Method of measurement: Questionnaire based on Visual Analog Scale index (VAS index). | — |
Secondary
| Measure | Time frame |
|---|---|
| FBS. Timepoint: Before the start of the intervention and 12 weeks after the start of the intervention. Method of measurement: blood test.;Glycosylated hemoglobin A1C. Timepoint: Before the start of the intervention and 12 weeks after the start of the intervention. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Seyedeh Tayebeh Rahideh
Iran University of Medical Sciences
Outcome results
None listed